Indigestion Preparations Market in Latin America to 2014 (OTC Healthcare)


February 23, 2011
20 Pages - SKU: DFMN6174022
License type:
Introduction

This databook provides key data and information on the Indigestion Preparations Market in Latin America (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope
  • Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
  • Category level company and brand share as well as distribution share information for 2007 and 2008
Highlights

The indigestion preparations category was valued at $760.2m in 2009, representing a CAGR of 7.4% since 2004.

By the end of 2014, the indigestion preparations category will be worth $1,011.3m, with an expected CAGR of 5.9% between 2009 and 2014.

The indigestion preparations market was led by tablets (representing 47.3% of the total value), followed by mixtures, with a 28.7% share. Powders accounts for the remaining 24% share.

GlaxoSmithKline Plc is the market leader with a 20.5% share of the market.

Reasons to Purchase
  • Develop business strategies by understanding the quantitative trends within the Indigestion Preparations Market in Latin America (OTC Healthcare)
  • Design effective marketing and sales strategies by identifying key market categories and segments
  • Identify key players within the market to plan lucrative M&A, partnerships and agreements



More Gastrointestinal reports by Datamonitor

Epidemiology: Inflammatory Bowel Disease – Early diagnosis and improved survival lead to increased patient populations by Datamonitor
IntroductionInflammatory bowel diseases (IBDs) are mainly composed of three chronic diseases; Crohn’s disease, ulcerative colitis, and indeterminate colitis. Although the etiology of inflammatory bowel disease ...
Product Profiles: Inflammatory Bowel Disease – Products compete for underserved patient groups by Datamonitor
IntroductionDatamonitor foresees rising competition in the Crohn’s disease and ulcerative colitis markets over the next five years. Several pipeline and marketed drugs are competing to ...
R&D Trends: Inflammatory Bowel Disease – Unmet needs fuel diverse pipeline by Datamonitor
Overview of the inflammatory bowel disease pipeline, preclinical to preregistration, with analysis by class, phase, and modality. Recent changes and future evolution of trial design ...
R&D Trends: Inflammatory Bowel Disease - Unmet needs fuel diverse pipeline by Datamonitor
IntroductionThe current pipeline is highly dynamic, with new entries compensating for heavy early-stage attrition. Several high profile candidates have failed in late-stage trials, but first-in-class ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!